The SyMRI 15 has undergone rigorous clinical validation. Credit: Cision / SyntheticMR.

SyntheticMR has secured CE marking for version 15 of its next-generation imaging solution, SyMRI Neuro.

The SyMRI 15 builds upon the previous SyMRI 3D (14) and introduces images that match the diagnostic capabilities of conventional methods.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

This imaging solution includes a host of advanced applications integrated into SyMRI’s post-processing suite and is set to transform the medical imaging landscape.

It has undergone rigorous clinical validation in a large multi-centre study across prominent US institutes, demonstrating that SyMRI 3D can effectively replace traditional 3D images, thereby improving efficiency and throughput.

These findings also reinforce the diagnostic accuracy of the solution.

See Also:

In addition to enhanced imaging capabilities, SyMRI 15 introduces tools designed to facilitate efficient patient monitoring. These tools provide contrast-weighted images and quantitative data.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

SyntheticMR CEO Ulrik Harrysson said: “This next generation of SyMRI 3D delivers unparalleled resolution and accuracy in brain imaging, transforming the field of medical diagnostics.”

Philips Healthcare has secured an exclusive agreement to distribute SyMRI 15 globally.

This partnership ensures that SyMRI 3D will be available in Philips’ worldwide price book, allowing the company to offer a complete imaging package to its customers.

SyntheticMR developed SyMRI, delivering several, adjustable contrast images and quantitative data from one five-minute scan.

SyMRI NEURO has been designed to deliver several tissue segmentations, contrast images and quantitative data on the brain.

This solution received a CE mark and 510(k) clearance from the US Food and Drug Administration.

The company is engaged in developing and marketing software solutions for magnetic resonance imaging (MRI).